Erratum: Suppression of AP1 transcription factor function in keratinocyte suppresses differentiation (PLoS ONE(2021) 7: 5(e36941)Doi: 10.1371/journal.pone.0036941);Suppression of AP1 transcription factor function in keratinocyte suppresses differentiation

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Han, Bingshe ^a   Rorke, Ellen A ^a   Adhikary, Gautam ^a   Chew, Yap Ching ^a   Xu, Wen ^a   Eckert, Richard L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR; DOMINANT NEGATIVE C JUN PROTEIN; HOMODIMER; INVOLUCRIN; MESSENGER RNA; PROTEIN AP1; PROTEIN C JUN; PROTEIN FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT; PRIMER DNA; PROTEIN PRECURSOR; TAM67 PEPTIDE; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; ONCOGENE C JUN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION TERMINATION; ANIMAL; BINDING COMPETITION; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GEL MOBILITY SHIFT ASSAY; GENETICS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY SEQUENCE;

MURINAE;

ANIMALS; BINDING, COMPETITIVE; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KERATINOCYTES; MICE; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-JUN; REAL-TIME POLYMERASE CHAIN REACTION; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTION FACTOR AP-1;

EID: 84861395908     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0247222     Document Type: Erratum

References (66)

1. Angel P, Szabowski A, Schorpp-Kistner M, (2001) Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 20: 2413-2423.
2. Karin M, Liu Z, Zandi E, (1997) AP-1 function and regulation. Curr Opin Cell Biol 9: 240-246.
3. Shaulian E, Karin M, (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131-E136.
4. Shaulian E, Karin M, (2001) AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400.
5. Mizuno H, Cho YY, Ma WY, Bode AM, Dong Z, (2006) Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes. Mol Carcinog 45: 1-9.
6. Shi B, Isseroff RR, (2005) Epidermal growth factor (EGF)-mediated DNA-binding activity of AP-1 is attenuated in senescent human epidermal keratinocytes. Exp Dermatol 14: 519-527.
7. Takahashi H, Ibe M, Nakamura S, Ishida-Yamamoto A, Hashimoto Y, et al. (2002) Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis. J Dermatol Sci 30: 94-99.
8. Adhikary G, Crish J, Lass J, Eckert RL, (2004) Regulation of involucrin expression in normal human corneal epithelial cells: a role for activator protein one. Invest Ophthalmol Vis Sci 45: 1080-1087.
9. Eckert RL, Efimova T, Balasubramanian S, Crish JF, Bone F, et al. (2003) p38 Mitogen-Activated Protein Kinases on the Body Surface- A Function for p38delta. J Invest Dermatol 120: 823-828.
10. Eckert RL, Crish JF, Efimova T, Dashti SR, Deucher A, et al. (2004) Regulation of involucrin gene expression. J Invest Dermatol 123: 13-22.
11. Efimova T, Broome AM, Eckert RL, (2004) Protein kinase Cdelta regulates keratinocyte death and survival by regulating activity and subcellular localization of a p38delta-extracellular signal-regulated kinase 1/2 complex. Mol Cell Biol 24: 8167-8183.
12. Raj D, Brash DE, Grossman D, (2006) Keratinocyte apoptosis in epidermal development and disease. J Invest Dermatol 126: 243-257.
13. Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, et al. (1995) c-fos is required for malignant progression of skin tumors. Cell 82: 721-732.
14. Kahn CR, Young E, Lee IH, Rhim JS, (1993) Human corneal epithelial primary cultures and cell lines with extended life span: in vitro model for ocular studies. Invest Ophthalmol Vis Sci 34: 3429-3441.
15. She QB, Chen N, Bode AM, Flavell RA, Dong Z, (2002) Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 62: 1343-1348.
16. Rutberg SE, Adams TL, Glick A, Bonovich MT, Vinson C, et al. (2000) Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes. Cancer Res 60: 6332-6338.
17. Florin L, Knebel J, Zigrino P, Vonderstrass B, Mauch C, et al. (2006) Delayed wound healing and epidermal hyperproliferation in mice lacking JunB in the skin. J Invest Dermatol 126: 902-911.
18. Passegue E, Jochum W, Behrens A, Ricci R, Wagner EF, (2002) JunB can substitute for Jun in mouse development and cell proliferation. Nat Genet 30: 158-166.
19. Schreiber M, Wang ZQ, Jochum W, Fetka I, Elliott C, et al. (2000) Placental vascularisation requires the AP-1 component fra1. Development 127: 4937-4948.
20. Fleischmann A, Hafezi F, Elliott C, Reme CE, Ruther U, et al. (2000) Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev 14: 2695-2700.
21. Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, et al. (2005) Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437: 369-375.
22. Crish JF, Howard JM, Zaim TM, Murthy S, Eckert RL, (1993) Tissue-specific and differentiation-appropriate expression of the human involucrin gene in transgenic mice: an abnormal epidermal phenotype. Differentiation 53: 191-200.
23. Crish JF, Zaim TM, Eckert RL, (1998) The distal regulatory region of the human involucrin promoter is required for expression in epidermis. J Biol Chem 273: 30460-30465.
24. Crish JF, Bone F, Banks EB, Eckert RL, (2002) The human involucrin gene contains spatially distinct regulatory elements that regulate expression during early versus late epidermal differentiation. Oncogene 21: 738-747.
25. Crish JF, Gopalakrishnan R, Bone F, Gilliam AC, Eckert RL, (2006) The distal and proximal regulatory regions of the involucrin gene promoter have distinct functions and are required for in vivo involucrin expression. J Invest Dermatol 126: 305-314.
26. Brown PH, Chen TK, Birrer MJ, (1994) Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9: 791-799.
27. Shimizu Y, Kinoshita I, Kikuchi J, Yamazaki K, Nishimura M, et al. (2008) Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant. Br J Cancer 98: 915-922.
28. Tichelaar JW, Yan Y, Tan Q, Wang Y, Estensen RD, et al. (2010) A dominant-negative c-jun mutant inhibits lung carcinogenesis in mice. Cancer Prev Res (Phila) 3: 1148-1156.
29. Jin X, Song X, Li L, Wang Z, Tao Y, et al. (2007) Blockade of AP-1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma. Mol Carcinog 46: 901-911.
30. Liu Y, Lu C, Shen Q, Munoz-Medellin D, Kim H, et al. (2004) AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity. Oncogene 23: 8238-8246.
31. Hennigan RF, Stambrook PJ, (2001) Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes. Mol Biol Cell 12: 2352-2363.
32. Feng Z, Li L, Ng PY, Porter AG, (2002) Neuronal differentiation and protection from nitric oxide-induced apoptosis require c-Jun-dependent expression of NCAM140. Mol Cell Biol 22: 5357-5366.
33. Madireddi MT, Dent P, Fisher PB, (2000) AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation. J Cell Physiol 185: 36-46.
34. Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, et al. (1996) Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Cell Growth Differ 7: 603-613.
35. Rorke EA, Adhikary G, Jans R, Crish JF, Eckert RL, (2010) AP1 factor inactivation in the suprabasal epidermis causes increased epidermal hyperproliferation and hyperkeratosis but reduced carcinogen-dependent tumor formation. Oncogene 29: 5873-5882.
36. Efimova T, LaCelle P, Welter JF, Eckert RL, (1998) Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK, AP1 signal transduction pathway. J Biol Chem 273: 24387-24395.
37. Cooper SJ, MacGowan J, Ranger-Moore J, Young MR, Colburn NH, et al. (2003) Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model. Mol Cancer Res 1: 848-854.
38. Dong Z, Crawford HC, Lavrovsky V, Taub D, Watts R, et al. (1997) A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol Carcinog 19: 204-212.
39. Li JJ, Rhim JS, Schlegel R, Vousden KH, Colburn NH, (1998) Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene 16: 2711-2721.
40. Shen Q, Zhang Y, Uray IP, Hill JL, Kim HT, et al. (2006) The AP-1 transcription factor regulates postnatal mammary gland development. Dev Biol 295: 589-603.
41. Thompson EJ, MacGowan J, Young MR, Colburn N, Bowden GT, (2002) A dominant negative c-jun specifically blocks okadaic acid-induced skin tumor promotion. Cancer Res 62: 3044-3047.
42. Young MR, Farrell L, Lambert P, Awasthi P, Colburn NH, (2002) Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dominant-negative c-jun. Mol Carcinog 34: 72-77.
43. Young MR, Li JJ, Rincon M, Flavell RA, Sathyanarayana BK, et al. (1999) Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci U S A 96: 9827-9832.
44. Efimova T, Eckert RL, (2000) Regulation of human involucrin promoter activity by novel protein kinase C isoforms. J Biol Chem 275: 1601-1607.
45. Eckert RL, Welter JF, (1996) Transcription factor regulation of epidermal keratinocyte gene expression. Mol Biol Rep 23: 59-70.
46. Eckert RL, Crish JF, Banks EB, Welter JF, (1997) The epidermis: genes on- genes off. J Invest Dermatol 109: 501-509.
47. Welter JF, Crish JF, Agarwal C, Eckert RL, (1995) Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity. J Biol Chem 270: 12614-12622.
48. Wei P, Inamdar N, Vedeckis WV, (1998) Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter. Mol Endocrinol 12: 1322-1333.
49. Adhikary G, Crish JF, Bone F, Gopalakrishnan R, Lass J, et al. (2005) An involucrin promoter AP1 transcription factor binding site is required for expression of involucrin in the corneal epithelium in vivo. Invest Ophthalmol Vis Sci 46: 1219-1227.
50. Banks EB, Crish JF, Welter JF, Eckert RL, (1998) Characterization of human involucrin promoter distal regulatory region transcriptional activator elements-a role for Sp1 and AP1 binding sites. Biochem J 331 (Pt 1): 61-68.
51. Balasubramanian S, Eckert RL, (2007) Curcumin suppresses AP1 transcription factor-dependent differentiation and activates apoptosis in human epidermal keratinocytes. J Biol Chem 282: 6707-6715.
52. Jang SI, Steinert PM, (2002) Loricrin expression in cultured human keratinocytes is controlled by a complex interplay between transcription factors of the Sp1, CREB, AP1, and AP2 families. J Biol Chem 277: 42268-42279.
53. Yoneda K, Hohl D, McBride OW, Wang M, Cehrs KU, et al. (1992) The human loricrin gene. J Biol Chem 267: 18060-18066.
54. Angel P, Hattori K, Smeal T, Karin M, (1988) The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55: 875-885.
55. Devary Y, Gottlieb RA, Lau LF, Karin M, (1991) Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 11: 2804-2811.
56. Stein B, Angel P, van Dam H, Ponta H, Herrlich P, et al. (1992) Ultraviolet-radiation induced c-jun gene transcription: two AP-1 like binding sites mediate the response. Photochem Photobiol 55: 409-415.
57. Berger I, Shaul Y, (1994) The human junD gene is positively and selectively autoregulated. DNA Cell Biol 13: 249-255.
58. Brown PH, Kim SH, Wise SC, Sabichi AL, Birrer MJ, (1996) Dominant-negative mutants of cJun inhibit AP-1 activity through multiple mechanisms and with different potencies. Cell Growth Differ 7: 1013-1021.
59. Thompson EJ, Gupta A, Stratton MS, Bowden GT, (2002) Mechanism of action of a dominant negative c-jun mutant in inhibiting activator protein-1 activation. Mol Carcinog 35: 157-162.
60. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227: 680-685.
61. Adhikary G, Crish JF, Gopalakrishnan R, Bone F, Eckert RL, (2005) Involucrin expression in the corneal epithelium: an essential role for Sp1 transcription factors. Invest Ophthalmol Vis Sci 46: 3109-3120.
62. Robinson NA, LaCelle PT, Eckert RL, (1996) Involucrin is a covalently crosslinked constituent of highly purified epidermal corneocytes: evidence for a common pattern of involucrin crosslinking in vivo and in vitro. J Invest Dermatol 107: 101-107.
63. Chew YC, Adhikary G, Wilson GM, Reece EA, Eckert RL, (2011) PKCdelta suppresses keratinocyte proliferation by increasing p21CIP1 level by a KLF4-dependent mechanism. J Biol Chem 286: 28771-28782.
64. Ramos-Nino ME, Blumen SR, Pass H, Mossman BT, (2007) Fra-1 governs cell migration via modulation of CD44 expression in human mesotheliomas. Mol Cancer 6: 81.
65. Diegmann J, Junker K, Gerstmayer B, Bosio A, Hindermann W, et al. (2005) Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry. Eur J Cancer 41: 1794-1801.
66. Kamioka N, Akahane T, Kohno Y, Kuroki T, Iijima M, et al. (2010) Protein kinase C delta and eta differently regulate the expression of loricrin and Jun family proteins in human keratinocytes. Biochem Biophys Res Commun 394: 106-111.